Evidence map›Paper›PMID 39670095›Full record

Observational studyPeerJ2024

Impact of white blood cell count on the development of contrast-induced acute kidney injury in patients receiving percutaneous coronary intervention.

Chengxiao Fu, Chenxi Ouyang, Guoping Yang, Jingle Li, Guiyang Chen, Yu Cao, Liying Gong

Abstract readObservational Study
In one paragraph

Observational study in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chengxiao Fu *Center of Clinical Pharmacology, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Chenxi Ouyang *College of Pharmacy, University Of South China, Hengyang, Hunan, China.
Guoping YangCenter of Clinical Pharmacology, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jingle LiCenter of Cardiology, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Guiyang ChenCenter of Clinical Pharmacology, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yu CaoCenter of Cardiology, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Liying GongCenter of Clinical Pharmacology, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate the efficacy of a pre-procedural white blood cell (WBC) count in the prediction of contrast-induced acute kidney injury (CI-AKI) risk in coronary artery disease patients receiving a percutaneous coronary intervention (PCI). This observational study comprises a sample of 1,013 coronary artery disease patients (including ACS and stable angina) receiving PCI, gathered from September 2015 to July 2017. CI-AKI incidence in the study population was 4.8% (49/1013). Patients in the CI-AKI group had significantly higher WBC counts than those in the non-CI-AKI group (10.41 ± 5.37

Indexed as

Acute Kidney InjuryContrast MediaCoronary Artery DiseasePercutaneous Coronary InterventionAgedFemaleHumansIncidenceLeukocyte CountMaleMiddle AgedRisk FactorsROC CurveContrast MediaContrast-induced acute kidney injuryCoronary heart diseasePercutaneous coronary interventionWhite blood cell

Identifiers

PMID39670095
PMCPMC11636986

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.